The text starts here.

Corporate Information

Company Name Eisai Co., Ltd.
Date Established December 6, 1941
Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone 81-3-3817-3700
Representatives Haruo Naito, Representative Corporate Officer and CEO
Hideki Hayashi, Representative Corporate Officer, Japan Business and CIO
Yutaka Tsuchiya, Representative Corporate Officer, Healthcare Policy and China Business
Hideshi Honda, Representative Corporate Officer and Asia Region President
Capital 44,986 million Yen (as of March 31, 2016)
Scope of Business Research and development, manufacture, sale and import and export of pharmaceuticals
Employees Consolidated : 9,877
Non-Consolidated : 3,504 (as of March 31, 2016)
Communication Offices 55 Communication Offices in Japan (as of March 31, 2016)
Production Plants Kawashima Plant (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
Eisai Manufacturing Ltd. (U.K.)
Eisai China Inc. Suzhou Plant (China)
Eisai (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China)
Eisai Pharmaceuticals India Pvt. Ltd. (India), etc.
Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Laboratory (Gifu Prefecture)
KAN Research Institute, Inc. (Hyogo Prefecture)
Eisai Inc. Andover Research Institute (U.S.A.)
Morphotek, Inc. (U.S.A.)
H3 Biomedicine Inc. (U.S.A.)
Eisai Ltd. Hatfield Research Institute (U.K.), etc.
Overseas Sales Offices Eisai Inc. (U.S.A.)
Eisai Ltd. (U.K.)
Eisai GmbH (Germany)
Eisai S.A.S. (France)
Eisai China Inc. (China)
Eisai Korea Inc. (South Korea), etc.

Related Links